Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?
M Hingorani, WP Colley, S Dixit… - The British journal of …, 2012 - academic.oup.com
The prognosis of patients with glioblastoma (GBM) remains poor, and the use of
hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit …
hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit …
Stereotactic radiosurgery and hypofractionated radiotherapy for glioblastoma
JL Shah, G Li, JL Shaffer, MI Azoulay, IC Gibbs… - …, 2018 - journals.lww.com
Glioblastoma is the most common primary brain tumor in adults. Standard therapy depends
on patient age and performance status but principally involves surgical resection followed by …
on patient age and performance status but principally involves surgical resection followed by …
The radiosurgery fractionation quandary: single fraction or hypofractionation?
Stereotactic radiosurgery (SRS), typically administered in a single session, is widely
employed to safely, efficiently, and effectively treat small intracranial lesions. However, for …
employed to safely, efficiently, and effectively treat small intracranial lesions. However, for …
[HTML][HTML] The radiosensitivity index predicts for overall survival in glioblastoma
We have previously developed a multigene expression model of tumor radiosensitivity (RSI)
with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would …
with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would …
A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas
R Shaffer, AM Nichol, E Vollans, M Fong… - International Journal of …, 2010 - Elsevier
PURPOSE: Volumetric modulated arc therapy (VMAT), the predecessor to Varian's
RapidArc, is a novel extension of intensity-modulated radiotherapy (IMRT) wherein the dose …
RapidArc, is a novel extension of intensity-modulated radiotherapy (IMRT) wherein the dose …
Central nervous system cancers, version 1.2015
LB Nabors, J Portnow, M Ammirati, J Baehring… - Journal of the National …, 2015 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous
System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS …
System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS …
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
A Omuro, K Beal, P Gutin, S Karimi, DD Correa… - Clinical Cancer …, 2014 - AACR
Purpose: Bevacizumab is associated with decreased vascular permeability that allows for
more aggressive radiotherapy schedules. We conducted a phase II trial in newly diagnosed …
more aggressive radiotherapy schedules. We conducted a phase II trial in newly diagnosed …
Pattern of recurrence of glioblastoma versus grade 4 IDH-mutant astrocytoma following chemoradiation: A retrospective matched-cohort analysis
Background and Purpose: To quantitatively compare the recurrence patterns of glioblastoma
(isocitrate dehydrogenase-wild type) versus grade 4 isocitrate dehydrogenase-mutant …
(isocitrate dehydrogenase-wild type) versus grade 4 isocitrate dehydrogenase-mutant …
Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues
D Amelio, S Lorentini, M Schwarz… - Radiotherapy and …, 2010 - Elsevier
Background and purpose: Intensity-modulated radiation therapy (IMRT) could represent a
new tool to improve the therapeutic ratio in the treatment of glioblastoma. This systematic …
new tool to improve the therapeutic ratio in the treatment of glioblastoma. This systematic …
Radiotherapy of glioblastoma 15 years after the landmark Stupp's trial: more controversies than standards?
T Kazda, A Dziacky, P Burkon, P Pospisil… - Radiology and …, 2018 - sciendo.com
Background. The current standard of care of glioblastoma, the most common primary brain
tumor in adults, has remained unchanged for over a decade. Nevertheless, some …
tumor in adults, has remained unchanged for over a decade. Nevertheless, some …